STRATEGY: Stick with Epicenter in 2H2021. Strong markets stay strong. US COVID-19 deaths are “unvaccinated” Americans COVID-19 cases could be rising, in part due to the spread of the more transmissible variants (Delta, etc.), but the approved vaccines seem to be containing the spread, and more importantly, limiting the severity of the disease (for a vaccinated individual). The AP published…
Energy positive returns 6 consecutive months. Stick with Epicenter in 2H2021.
A financial market resource for the every-day investor and trader.
-
Assessing and Addressing The Market Season
Seth Golden, , Research Reports, 0
We’re back! It has been a couple of weeks since our last weekly Research Report, but we hope some...
-
Crazy Time For Markets and Investors
Seth Golden, , Research Reports, 0
In the past trading week, investors/traders were once again at the mercy of trade headlines. It was only 2...
-
Housing Struggles Not Mirrored By Markets
Seth Golden, , Research Reports, 0
The Leuthold Group The Major Trend Index was unchanged at a High Neutral reading of +1 in the week...
-
Chaos, Mayhem = Opportunity
Seth Golden, , Research Reports, 0
Good weekend to all ‼️ This weekend is our off-reporting weekend but we continue to deliver market insights, analysis,...
-
Yields Take Center Stage Ahead of Q3 2018 Earnings Season
Seth Golden, , Research Reports, 0
There is a great deal to discuss in this week’s research report, but we would be remised if we...
-
Summer Doldrums and Fool-Bearing Price Action
Seth Golden, , Research Reports, 0
The table has turned. In 2022, the S&P 500 (SPX) and peer indices finished the first half of the...
-
Fitbit Misses Q3 Expectations And Lowers Full Year Guidance
Seth Golden, , Research Reports, 0
It’s not just that Fitbit (FIT) reported a miss on the top-line, but more so that the company lowered...
-
Weekly Warm-up: Defensive Leadership Can Continue as Earnings Cuts Begin
Seth Golden, , Research Reports, 0
While Defensives are the clear leader, most investors aren’t there, leaving more upside potential as earnings cuts begin. Counter-trend...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00